The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Nektar Therapeutics

Nasdaq: NKTR
Last

(U.S.) $22.30

Today's change-0.13 -0.58%
Updated September 25 11:21 AM EDT. Delayed by at least 15 minutes.
 

Nektar Therapeutics

Nasdaq: NKTR
Last

(U.S.) $22.30

Today's change-0.13 -0.58%
Updated September 25 11:21 AM EDT. Delayed by at least 15 minutes.

Nektar Therapeutics down (U.S.)$0.13

Nektar Therapeutics is lower today, dropping (U.S.)$0.13 or 0.58% to (U.S.)$22.30. Shares have lost 1.33% over the last five days, but have gained 81.74% over the last year to date. This security has outperformed the S&P 500 by 3.78% during the last year.

Key company metrics

  • Open(U.S.) $22.29
  • Previous close(U.S.) $22.43
  • High(U.S.) $22.50
  • Low(U.S.) $22.06
  • Bid / Ask(U.S.) $22.29 / (U.S.) $22.32
  • YTD % change+81.74%
  • Volume193,611
  • Average volume (10-day)1,131,872
  • Average volume (1-month)1,044,112
  • Average volume (3-month)1,191,413
  • 52-week range(U.S.) $11.41 to (U.S.) $24.88
  • Beta1.46
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.40
Updated September 25 11:21 AM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue35253736
Total other revenue--------
Total revenue35253736
Gross profit26193129
Total cost of revenue9677
Total operating expense85797069
Selling / general / administrative16121310
Research & development60615052
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)----0--
Other operating expenses, total--------
Operating income-51-54-32-33
Interest income (expense), net non-operating-10-10-10-11
Gain (loss) on sale of assets--------
Other--------
Income before tax-60-64-42-43
Income after tax-60-64-42-43
Income tax, total0000
Net income-60-64-42-43
Total adjustments to net income--------
Net income before extra. items-60-64-42-43
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-60-64-42-43
Inc. avail. to common incl. extra. items-60-64-42-43
Diluted net income-60-64-42-43
Dilution adjustment--------
Diluted weighted average shares155154149137
Diluted EPS excluding extraordinary itemsvalue per share-0.39-0.42-0.28-0.32
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.39-0.42-0.28-0.32